Brad Wiggins’ performance earlier this week in the first stage of the Tour of Romandie was a rare treat for the modern cycling fan: a real Grand Tour contender duking it and taking the win in a bunch sprint. It wasn’t in a Grand Tour, of course, and it took a couple pretty serious climbs…
Month: April 2012
Liege-Bastogne-Liege 2012 – How The Race Was Won
A little later than I like to be on these sorts of things, but what can I say–with a new corporate sponsor on board, there’s bound to be a little meddling in editorial. Also, some of you might also have noticed that I was moving around a little bit during the event itself. [right-click for…
Amstel Gold 2012 – How The Race Was Won
Another new course this spring, though certainly nothing on par with Flanders’ change-up. Despite the re-worked parcours, this one unfolded sleepily, feeling at points like a Tour de France sprint stage. But comic relief at the back, some lively riding as the break wore down and an attack from a very surprising source set the…
2012 Paris-Roubaix – How The Race Was Won
Tom Boonen powers away to win number four in an historic display of strength and commitment. The only thing to feel bad about was that we didn’t get to see Fabian Cancellara shoot it out with him. Of course, had Cance been at the start line, Omega Pharma would have doubtlessly played their cards a…
Tour of Flanders 2012 — How The Race Was Won
An ambiguously-branded video recap and commentary for the 2012 Tour of Flanders. Some backstory might be helpful. [right-click for iTunes-compatible download] You might get another one of these this year. You also might not. The way I made this was by not sleeping last night and that’s not really sustainable. Or pleasant. Consider it a…
How to Succeed in Bike Racing Without Really Trying
In 2005, Tom Boonen’s ascendancy was nothing short of meteoric, and his failure to maintain that level of success since has prompted no shortage of discussion. While I was one of the first to suggest that the Belgian might just be the first of a new generation rather than the next Merckx, I’ve also been…